Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
3.1%
% of FHLC's 349 holdings also in THNR
43.5%
% of THNR's 23 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus THNR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 15.7% | 11.3% |
|
MERCK & CO. INC. | 3.8% | 4.7% | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% | 5.0% | 3.3% |
|
AMGEN INC | 2.8% | 4.6% | 2.8% |
|
PFIZER INC | 2.4% | 4.6% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to THNR
|
UNITEDHEALTH GROUP INC | 7.3% |
|
JOHNSON & JOHNSON | 6.4% |
|
ABBVIE INC | 6.1% |
|
ABBOTT LABORATORIES | 3.8% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
GILEAD SCIENCES INC | 2.3% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
DANAHER CORP | 2.2% |
|
STRYKER CORP | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
FHLC Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -13.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.2% |
|
WEST PHARMACEUTICAL SERVICES | -4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.7% |
 |
ROCHE HOLDING LTD | -4.7% |
 |
INNOVENT BIOLOGICS, INC. | -4.7% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.5% |
|
ELI LILLY & CO | -4.4% |
|
HIMS & HERS HEALTH, INC. CLASS A | -3.5% |
|
MITSUBISHI CHEMICAL HOLDINGS | -3.5% |